Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Rachel Burgoyne.

Newcastle AuthorsTitleYearFull text
Lucy Gee
Dr Ben Barron-Millar
Dr Marco Zaki
Dr Saimir Luli
Rachel Burgoyne
et al.
Anti–Cholestatic Therapy with Obeticholic Acid Improves Short-Term Memory in Bile Duct–Ligated Mice2023
Dr Jack Leslie
Hannah Paish
Amy Collins
Rebecca Scott
Abi Watson
et al.
A Mammalian Target of Rapamycin-Perilipin 3 (mTORC1-Plin3) Pathway is essential to Activate Lipophagy and Protects Against Hepatosteatosis2021
Dr Massimo Younes
Rachel Burgoyne
Dr Dina Tiniakos
Dr Olivier Govaere
Clinical implications of hepatic progenitor cell activation in non-alcoholic fatty liver disease2021
Dr Lee Borthwick
Ben Barksby
Rachel Burgoyne
Rory Barnes
Professor Andrew Fisher
et al.
Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic disease2021
Rachel Burgoyne
Professor Andrew Fisher
Dr Lee Borthwick
The role of epithelial damage in the pulmonary immune response2021
Dr Jack Leslie
Dr Marina Garcia Macia
Dr Saimir Luli
Dr Julie Worrell
William Reilly
et al.
c-Rel orchestrates energy-dependant epithelial and macrophage reprogramming in fibrosis2020
Dr Jack Leslie
Benjamin Millar
Alicia Del Carpio Pons
Rachel Burgoyne
Joseph Frost
et al.
FPR-1 is an important regulator of neutrophil recruitment and a tissue-specific driver of pulmonary fibrosis2020
Dr Lee Borthwick
Ben Barksby
Rachel Burgoyne
Rory Barnes
Professor Andrew Fisher
et al.
Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis2020